women-in-stem
(23)
Biju Muduli Spent Two Decades Learning What Makes Enterprise Buyers Move
Her route from electrical engineering to the C-suite runs through CRM systems, global demand engines, cybersecurity and now agentic contract software. The connecting idea is simple: make complicated technology legible, measurable and useful.
Liz O’Day Put Science on a T-Shirt. Then She Put It on a Deadline.
Before Olaris, Liz O’Day stored science-themed shirts in her kitchen and quietly wondered whether she counted as an entrepreneur. Twelve years into building a diagnostics company, the answer lives in her habit of turning difficult questions into things people can actually use.
Parastoo Khoshakhlagh Is Teaching Cells to Skip the Waiting
The GC Therapeutics co-founder has moved from neural gels to spaceflight to a library for programming cell fate. Her recurring move is simple to describe and difficult to execute: turn biology's long recipes into instructions.
Vidya Ramnath
From a manufacturing floor in Singapore to Emerson's executive office, Vidya Ramnath has spent three decades learning how industrial technology works - and how to make its value understood.
Nicole Richards
Nicole Richards is the founding CEO of Allonnia, a Boston-based synthetic biology company that engineers microbes to destroy forever chemicals like PFAS and 1,4-dioxane, and to pull critical minerals out of ore and waste streams. A chemical engineer with nearly three decades in water, mining and specialty chemicals, she spun Allonnia out of Ginkgo Bioworks' Ferment Consortium in 2020 with a $40M Series A and has since raised more than $109M in total funding.
Rema Matevosyan
Rema (Hripsime) Matevosyan is the co-founder and CEO of Near Space Labs, a Brooklyn-based company that flies helium-lifted robotic aircraft called Swift into the stratosphere to photograph the Earth at 7-centimeter resolution. Born and educated in Armenia, trained as an applied mathematician in Moscow, she left a PhD program two weeks into an entrepreneurship class to build what she calls her own little space program. In April 2025 the company closed a $20M Series B led by Bold Capital Partners, bringing total funding above $40M, with insurance carriers as anchor customers using the imagery to model wildfire and hurricane damage.
Karen Gondoly
Karen Gondoly is the CEO of Leostream Corporation, the Boston-area company whose vendor-neutral connection broker and gateway software quietly runs the remote desktops of Hollywood studios, oil rigs, trading floors, and government agencies. An MIT-trained aeronautical engineer who once left tech to become a head pastry chef, she answered a Craigslist ad for a technical writing gig, was offered a product manager role instead, and rose to run the company by 2016. Under her leadership Leostream won a 2022 Engineering, Science & Technology Emmy and stayed cash-flow positive without new funding since 2008.
Rachel Seevers
Rachel Seevers is a Strategy Associate in the Office of the CEO at The Nuclear Company, America's nuclear infrastructure platform. A Lexington, Kentucky native, she made her name as a teenage inventor - winning the $50,000 Intel Foundation Young Scientist Award in 2019 for a jellyfish-inspired underwater propulsion device that improved efficiency by up to 37 percent, after earlier building the patent-pending 'Virtual Winglet' aircraft wing over 7,000 hours of work. She studied mechanical engineering and education at Harvard, cut her professional teeth as a Deloitte analyst, and founded STEM programs to bring girls and underserved kids into science. Now she brings that biomimic's eye for efficiency to the hard problem of building nuclear fleets on time and on budget.
Brianna Wronko-Stevens
Brianna Wronko-Stevens is a University of Pennsylvania-trained bioengineer who turned a senior design project into HueDx (formerly Group K Diagnostics), a Philadelphia diagnostics company that reads lab-grade results off a color-changing card and a smartphone camera - no lab, no reader, no waiting days. Inspired by an HIV clinic internship at 17, she built a platform to deliver fast, quantitative results to the patients who can least afford to wait. She founded the company in 2017, served as CEO through a 2023 rebrand and raised millions in funding, then stepped into the Chief Scientific Officer seat to focus on the science.
Aihua Fu
Aihua Fu is a nanobiotechnologist and the co-founder, President and CEO of NVIGEN Inc., a San Jose nanobiotechnology company building molecularly engineered magnetic and fluorescent nanoparticles for cancer detection and personalized medicine. Trained as a chemist under Nobel-track nanoscience pioneer A. Paul Alivisatos at UC Berkeley and as a postdoc at Stanford, she turned quantum-dot and magnetic-bead research into commercial tools for liquid biopsy, cfDNA extraction, single-cell sequencing and circulating tumor cell capture. Her flagship NVIGEN X and NERNST-Seq platforms aim to read DNA, RNA, protein and cell signals together to predict cancer recurrence early and guide therapy.
Christine Schindler
Christine Schindler is the co-founder and CEO of PathSpot, the maker of the HandScanner - a device that mounts beside a kitchen sink, scans a worker's just-washed hands with light, and flags invisible contamination in seconds. A Duke-trained biomedical engineer who first built low-cost medical tools near Mount Kilimanjaro, she prototyped PathSpot's algorithms in her apartment bathroom, sold her car to fund it, and grew the company into a food-safety operating system used across the restaurant industry. She is a Forbes 30 Under 30 honoree, a Time Best Invention recognizee, and the founder of the nonprofit Girls Engineering Change.
Rachel Slaybaugh
Rachel Slaybaugh is a General Partner at DCVC, the deep tech venture firm, where she leads climate, sustainability, and energy investments. A nuclear engineer by training - she once operated a reactor as an undergrad at Penn State - she spent eight years as a tenured Associate Professor at UC Berkeley, ran the Cyclotron Road accelerator division at Lawrence Berkeley National Laboratory, and served as a Program Director at the U.S. Department of Energy's ARPA-E, where she created the nuclear fission program and helped fund over 30 companies. She co-founded the Good Energy Collective and the Nuclear Innovation Bootcamp, and now backs companies like Fervo Energy, Brimstone, Radiant Industries, Zap Energy, Fourth Power, and Equilibrium Energy at DCVC.
Rachel Haurwitz
Rachel Haurwitz is the President and CEO of Caribou Biosciences, a clinical-stage biopharmaceutical company she co-founded in 2011 with Nobel laureate Jennifer Doudna and colleagues Martin Jinek and James Berger. A pioneer in CRISPR commercialization, Haurwitz earned her PhD from UC Berkeley under Doudna's mentorship — she was the first student in the lab to work on CRISPR — and pivoted from academia to industry to bring genome-editing technology to patients. Under her leadership, Caribou has developed a proprietary Cas12a-based platform (chRDNA technology) enabling precise, multiplex genome editing for off-the-shelf allogeneic CAR-T and CAR-NK cell therapies targeting blood cancers and autoimmune diseases. She also co-founded Intellia Therapeutics in 2014 and has been recognized on Forbes 30 Under 30, Fortune 40 Under 40, and featured in Walter Isaacson's bestseller 'The Code Breaker.'
Olgica Bakajin
Olgica Bakajin is the CEO and Founder of Porifera Inc., a San Leandro, California-based company pioneering forward osmosis membrane technology for the food, beverage, and industrial water sectors. A physicist by training - B.A. from the University of Chicago and Ph.D. from Princeton - she spent nearly a decade at Lawrence Livermore National Laboratory developing carbon nanotube membranes that move water 1,000x faster than conventional materials. Her 2006 Science paper on carbon nanotube desalination became the most-cited chemistry article in the journal. In 2009 she spun Porifera out of LLNL, and the company now serves 100+ customers across 20+ countries, helping breweries, coffee roasters, and winemakers concentrate their products without heat, preserving flavor, aroma, and nutrients while slashing energy use by up to 80%.
Sampriti Bhattacharyya
Sampriti Bhattacharyya is the founder and CEO of Navier, the company building America's first all-electric hydrofoiling boat. She grew up in Kolkata, India, arrived in the US at 20 with $200, and went on to earn a PhD in mechanical engineering from MIT. After her first venture — Hydroswarm, an underwater drone startup — she co-founded Navier in 2020 with MIT engineer Reo Baird. Their flagship product, the N30, is a 30-foot, eight-passenger electric foiling yacht that glides four feet above the water at 35 knots, runs 10 times more efficiently than gas-powered boats, and delivered its first customer unit in October 2024. Navier's investors include Google co-founder Sergey Brin and Android co-founder Rich Miner.
Vasiliki Demas
Vasiliki 'Vicky' Demas, PhD, is the CEO and founder of identifeye HEALTH, an AI-enabled retinal imaging company that brings specialized eye screening to primary care settings. A chemical engineer by training with a PhD from UC Berkeley and a postdoc at Lawrence Berkeley National Lab, she cut her teeth as a founding member of Google Life Sciences (which became Verily) and helped build foundational technology for GRAIL's Galleri multi-cancer early detection test. At identifeye HEALTH — which she joined in 2021 and rebranded from Tesseract Health — she leads a 38-person team developing a portable, FDA-registered AI retinal camera that lets minimally trained staff detect diabetic retinopathy and systemic disease markers in the same visit patients already make to their primary care doctor.
Christina Smolke
Christina Smolke is the CEO and Co-Founder of Antheia, Inc., a Menlo Park-based synthetic biology company programming yeast to manufacture complex pharmaceutical ingredients — including the active ingredient in Narcan — in days rather than the years required by traditional plant cultivation. A Stanford professor turned biotech entrepreneur, she pioneered the engineering of baker's yeast to produce opioids and other plant-derived medicines, raising over $175 million to bring her lab breakthroughs to global pharmaceutical supply chains.
Alyson Watson
Alyson Watson is the CEO and Chair of the Board of Woodard & Curran, a Portland, Maine-based integrated science, engineering, design-build, and operations firm specializing in water and environmental challenges. A Stanford-trained chemical engineer and licensed PE, she became the firm's third CEO in 2021 — and its first woman to hold that title — after more than 20 years leading water resources projects and building environmental consulting teams across the western United States. A self-described 'water brat' with roots in the industry, Watson is a passionate advocate for clean water access, outcome-based contracting, and employee ownership, guiding a firm of 1,300 people across 27 offices nationwide.
Anna-Katrina Shedletsky
Anna-Katrina Shedletsky is the CEO and co-founder of Instrumental Inc., a Palo Alto-based AI manufacturing software company she founded in 2015 after six years at Apple—where she spent 300+ days in Chinese factories debugging manufacturing issues for the iPod and led product design for the original Apple Watch. At Instrumental, she is converting those factory-floor battle scars into software that uses AI and cameras to find defects and eliminate waste on electronics assembly lines, with customers including Cisco, Honeywell, Bose, Meta, and Lenovo. The company has raised $80.3M in total funding and was named Fast Company's #2 Most Innovative Manufacturing Company in 2021. She also founded the Women in STEM Mentorship Program (WISMP) at Stanford in 2013, which now spans multiple universities.
Peyton Greenside
Peyton Greenside is the CEO and co-founder of BigHat Biosciences, a San Mateo-based biotech company she co-founded in 2019 with Mark DePristo. A pioneer of deep learning applied to life science, Greenside combined a PhD in Biomedical Informatics from Stanford, an MPhil from Cambridge, and a BA in Applied Math from Harvard into a singular mission: use machine learning and synthetic biology to design safer, more effective antibody therapeutics faster than anyone thought possible. BigHat's Milliner platform generates thousands of unique antibody designs per week, and the company has raised $174M in total funding with pharma partnerships spanning Amgen, Merck, AbbVie, Johnson & Johnson, and Eli Lilly.
Jess Ramos
Jess Ramos is a data analytics educator, LinkedIn Top Voice, and founder of Big Data Energy - a media and education brand with 500,000+ followers across platforms. With an MSBA from the University of Georgia, she turned a corporate analytics career (peaking at $153K at Crunchbase) into a thriving solo business after being laid off in 2023. She runs a Substack newsletter with 45,000+ subscribers, teaches SQL to 50,000+ students via LinkedIn Learning, and has brand partnerships with IBM, AWS, Snowflake, NFL, and Claude (Anthropic). Her origin story - doubling her salary 110% in 11 months - became a viral moment that built her community of data professionals seeking real, human-centric career guidance.
Emily Oster
Emily Oster is a Harvard-trained economist, Brown University professor, and the mind behind ParentData - a platform transforming how millions of parents make decisions. With four consecutive New York Times bestsellers, TIME's 100 Most Influential People recognition, and over a million books sold, she wields data like a scalpel against pregnancy myths and parenting guilt, convincing readers that evidence beats anxiety every time.
Katelyn Jetelina
Dr. Katelyn Jetelina is an epidemiologist, data scientist, and one of America's most influential science communicators. She founded Your Local Epidemiologist (YLE) in March 2020 as a few sentences to update her UT Health students about COVID-19 - and somehow that turned into a 365,000-subscriber newsletter reaching people in 133 countries with over 500 million total views. Named a TIME100 Most Influential Person in Health, she translates complex public health science into actionable insights twice a week, covering everything from vaccines and bird flu to gun violence and federal health policy. She holds a PhD in Epidemiology and Biostatistics, consults with the CDC, and serves as an adjunct professor at Yale School of Public Health - all while raising two daughters and having visited 50+ countries.